Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Open Access | Times Cited: 295

Showing 101-125 of 295 citing articles:

Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions
Ivy Lee Jia Jia, Simona Zampetti, Paolo Pozzilli, et al.
Diabetes Research and Clinical Practice (2024), pp. 111879-111879
Open Access | Times Cited: 3
A Narrative Review of the Interplay between Carbohydrate Intake and Diabetes Medications: Unexplored Connections and Clinical Implications
Mabitsela Hezekiel Mphasha, Rajesh Vikram Vagiri
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 624-624
Open Access
Foeniculum vulgare (Fennel): A comprehensive review of its anti-diabetic properties
Nozwelo Ntombizami Ncube, Jeena Gupta
Asian Pacific Journal of Tropical Biomedicine (2025)
Open Access
Evidence of phenolic compounds as modulators of ChREBP and NRF2 in type 2 diabetes: a review of their potential for drug development
Carina Proença, M. Graça Lobo, Ana T. Rufino, et al.
Phytochemistry Reviews (2025)
Closed Access
Insulin Resistance in Type 1 Diabetes and Its Treatment Strategies
全昊 孙
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 311-317
Closed Access
Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks
Ahmad Mamoun Rajab, Sam M. Pearson, Ramzi Ajjan
Diabetes Obesity and Metabolism (2025)
Open Access
Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective
Ingra Gagno Nicchio, Thamiris Cirelli, Lucas César da Costa Quil, et al.
Biochemical Pharmacology (2025), pp. 116908-116908
Closed Access
Development and Validation of QBD-Assisted Using Central Composite Design RP-HPLC Method for Lobeglitazone Sulfate and Glimipiride in Bulk and Its Combined Dosage Form
Ajabaluku JULIET, Punniyakoti T. Veeraveedu
Chromatographia (2025)
Closed Access
Harnessing phytochemicals to combat diabetes: Insights into molecular pathways and therapeutic advances
Putri Cahaya Situmorang, Cut Fatimah Zuhra, Anisa Lutfia, et al.
Journal of Functional Foods (2025) Vol. 128, pp. 106799-106799
Closed Access
Thiazolidinedione Use and Cardiovascular Outcomes in Patients With Type 2 Diabetes Who Underwent Carotid Artery Revascularization
Joonsang Yoo, Jimin Jeon, Seok‐Jae Heo, et al.
Journal of the American Heart Association (2025)
Open Access
Re-assessing the risk-benefit profile of Thiazolidinediones: Cardiovascular Risks and Stroke Prevention Through Real-World Data
Fei Lu, Yingjie Zhao
Endocrine Practice (2025)
Closed Access
Type 2 diabetes mellitus – conventional therapies and future perspectives in innovative treatment
Barbara Gieroba, Adrianna Kryska, Anna Sroka‐Bartnicka
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102037-102037
Closed Access
Pharmacological management of vascular endothelial dysfunction in diabetes: TCM and western medicine compared based on biomarkers and biochemical parameters
Patrick Kwabena Oduro, Jingmei Fang, Lu Niu, et al.
Pharmacological Research (2020) Vol. 158, pp. 104893-104893
Closed Access | Times Cited: 24
The forgotten type 2 diabetes mellitus medicine: rosiglitazone
Bo Xu, Aoxiang Xing, Shuwei Li
Diabetology International (2021) Vol. 13, Iss. 1, pp. 49-65
Open Access | Times Cited: 22
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors
Syed Nazreen
Archiv der Pharmazie (2021) Vol. 354, Iss. 9
Closed Access | Times Cited: 21
Dietary Control of Inflammation and Resolution
B. Sears, Asish K. Saha
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 21
Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
Piotr Przybycień, Danuta Gąsior‐Perczak, Wojciech Placha
Cells (2022) Vol. 11, Iss. 16, pp. 2569-2569
Open Access | Times Cited: 16
The circadian rhythm: an influential soundtrack in the diabetes story
Amirali Hariri, Mina Mirian, Ali Zarrabi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis
Johanna Melin, Maria Forslund, Simon Alesi, et al.
Clinical Endocrinology (2023) Vol. 100, Iss. 2, pp. 149-163
Open Access | Times Cited: 9
Ginsenoside Rg3 Protects against Diabetic Cardiomyopathy and Promotes Adiponectin Signaling via Activation of PPAR-γ
Chenyang Zhang, Huifang Yu, Jingxue Ye, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16736-16736
Open Access | Times Cited: 9
Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review
William V. Tamborlane, Naim Shehadeh
Advances in Therapy (2023) Vol. 40, Iss. 11, pp. 4711-4720
Open Access | Times Cited: 8
Thiazolidinedione as a Promising Medicinal Scaffold for the Treatment of Type 2 Diabetes
Gurvinder Singh, Rajesh Kumar, Desna D.S., et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 8
Cell-state dependent regulation of PPARγsignaling by ZBTB9 in adipocytes
Xuan Xu, Alyssa Charrier, Sunny Congrove, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview
Ojasvi Gupta, Gita Chawla, Tathagata Pradhan
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 20, pp. 1800-1821
Closed Access | Times Cited: 3
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials
Zonglin Li, Chu Lin, Xiaoling Cai, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Scroll to top